| Target Price | $348.45 |
| Price | $263.27 |
| Potential | 32.35% |
| Number of Estimates | 24 |
| 24 Analysts have issued a price target Constellation Energy 2027 . The average Constellation Energy target price is $348.45. This is 32.35% higher than the current stock price. The highest price target is $463.05 75.88% , the lowest is $292.90 11.25% . | |
| A rating was issued by 28 analysts: 23 Analysts recommend Constellation Energy to buy, 5 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Constellation Energy stock has an average upside potential 2027 of 32.35% . Most analysts recommend the Constellation Energy stock at Purchase. |
23 Analysts have issued a sales forecast Constellation Energy 2026 . The average Constellation Energy sales estimate is
This results in the following potential growth metrics:
21 Analysts have issued an Constellation Energy EBITDA forecast 2026. The average Constellation Energy EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
29 Constellation Energy Analysts have issued a net profit forecast 2026. The average Constellation Energy net profit estimate is
This results in the following potential growth metrics and future Net Margins:
29 Analysts have issued a Constellation Energy forecast for earnings per share. The average Constellation Energy EPS is
This results in the following potential growth metrics and future valuations:
Constellation Energy...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Sep 18 2026 |
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Aug 21 2026 |
| Argus Research |
Buy
➜
Buy
|
Unchanged | Aug 11 2026 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Jul 28 2026 |
| UBS |
Buy
➜
Buy
|
Unchanged | Jul 28 2026 |
| TD Cowen |
Buy
➜
Buy
|
Unchanged | Jul 27 2026 |
| Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Jul 27 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Sep 18 2026 |
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Aug 21 2026 |
|
Unchanged
Argus Research:
Buy
➜
Buy
|
Aug 11 2026 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Jul 28 2026 |
|
Unchanged
UBS:
Buy
➜
Buy
|
Jul 28 2026 |
|
Unchanged
TD Cowen:
Buy
➜
Buy
|
Jul 27 2026 |
|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Jul 27 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


